AccStrat Biotechnology Co.,Ltd.

Founded in 2018, AccStrat Biotechnology Co., Ltd. has an independent R&D and standardized production base of 15,000 square meters, focusing on the research and development, production and sales of in vitro diagnostic reagent raw materials and drug concentration monitoring kits, and providing overall solutions for POCT products. After years of deep cultivation and polishing, AccStrat Biotech has established stable technical platforms such as small molecule drug structure derivation and characterization, artificial antigen directed synthesis, animal immunity and antibody screening, murine hybridoma, rabbit monoclonal antibody platform and recombinant expression. It has built colloidal gold, fluorescence immunochromatography and magnetic particle chemiluminescence detection platforms, and strictly controls the quality, and has passed the ISO13485：2016 quality management system certification, and has obtained three medical device registration certificates： vancomycin, methotrexate and dry fluorescence immunoassay analyzer. At present, the company provides hundreds of antigens and antibodies for sale at home and abroad, which has been recognized and praised by downstream customers! AccStrat Biotech will continue to innovate and continue to polish more excellent products to serve global partners!